Focal One is the leading brand in robotic focal therapy for prostate cancer, utilizing Robotic Focal HIFU (High Intensity Focused Ultrasound) technology. This groundbreaking platform is controlled by urologists, offering precise and non-invasive treatment options with minimal side effects. Focal One's HIFU Robotic System uses high-performance ultrasound waves to target and destroy affected prostate tissue while sparing healthy surrounding tissue.

The system's advanced features, such as the Robotic Positioning System, Open-Platform Fusion Software, Integrated Workstation, and Dynamic Focusing Probe, provide enhanced precision, flexibility, and expanded reach for optimal treatment outcomes. Physicians benefit from adding Focal One to their prostate cancer management programs, as it fills an important gap in therapy options. Patients also benefit from this technology, as it allows them to maintain their quality of life with minimal side effects.

Focal One is globally recognized and available in multiple countries, with regulatory clearance in the United States, Europe, Canada, Korea, Russia, Brazil, and more. Join the movement of urologists around the world by exploring the possibilities offered by Focal One and revolutionizing prostate cancer treatment